- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0029688

Sinogene Laboratories Private Limited
About Sinogene Laboratories Private Limited
Data last updated:
Sinogene Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 08 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2020PTC140695.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Guravaiah Nalagam and Praveena Nalajam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.03 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.39 Lakh (net margin 3.5%) and EBITDA of ₹2.19 Lakh (EBITDA margin 5.5%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.
Sinogene Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0029688).
Company details
Recognitions & Rankings of Sinogene Laboratories
Contact details
Sinogene Laboratories Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address4 – 1 – 216/111 Flat No. 30 Sai Kiran Residency Karthikeya Nagar N, Acharam, Hyderabad, Telangana, India – 500076
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sinogene Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sinogene Laboratories Private Limited, buy the company report.
Financials of Sinogene Laboratories Private Limited
FY 2025 filings availableSinogene Laboratories Private Limited reported revenue of ₹40.03 Lakh (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 3%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sinogene Laboratories Private Limited, buy the company report.
Board of directors of Sinogene Laboratories Private Limited
Sinogene Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Guravaiah Nalagam | Director | 08 Jun 2020 | 6 Years 4 Months | Current |
| Praveena Nalajam | Director | 08 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
Sinogene Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Steenbrass Pharmaceuticals Private Limited | ₹40.17 Lakh (FY 2015) | -12.0% | Mumbai, Maharashtra, India | |||
| V3s Life Sciences Private Limited | ₹40.15 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Venkateshwara Chemical Industries Private Limited | ₹40.13 Lakh (FY 2025) | -99.0% | Ghaziabad, Uttar Pradesh, India | |||
| Armn Pharmaceutical India Private Limited | ₹40.08 Lakh (FY 2023) | -1.0% | Panipat, Haryana, India | |||
| Zoithross Life Sciences Private Limited | ₹40.07 Lakh (FY 2025) | 19.0% | Pune, Maharashtra, India | |||
| Sinogene Laboratories Private Limitedthis company | ₹40.03 Lakh (FY 2025) | ₹1.39 Lakh | 3.5% | 5.0% | Hyderabad, Telangana, India | |
| Seavens Pharmaceutical Private Limited | ₹40 Lakh (FY 2025) | -6.0% | Jaipur, Rajasthan, India | |||
| Dharani Ayurvedics Private Limited. | ₹39.97 Lakh (FY 2024) | 154.0% | Palakkad, Kerala, India | |||
| NCB Pharma Private Limited | ₹39.96 Lakh (FY 2025) | 123.0% | Secunderabad, Telangana, India | |||
| Erevna Pharma Private Limited | ₹39.96 Lakh (FY 2025) | -92.0% | Medchal Malkajgiri, Telangana, India | |||
| Allevus Health Care Private Limited | ₹39.96 Lakh (FY 2025) | 10.0% | Guwahati, Assam, India |
To see the full peer comparison of Sinogene Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sinogene Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sinogene Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sinogene Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sinogene Laboratories Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Guravaiah Nalagam was appointed as Director on 08 Jun 2020.
Frequently asked questions
Sinogene Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 08 June 2020 (6+ years old) and is registered under CIN U24304TG2020PTC140695.
Sinogene Laboratories has 2 current directors:
- Guravaiah Nalagam - Director
- Praveena Nalajam - Director
The latest financial statements of Sinogene Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Sinogene Laboratories is U24304TG2020PTC140695. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sinogene Laboratories was incorporated on 08 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sinogene Laboratories by revenue are Steenbrass Pharmaceuticals Private Limited, V3s Life Sciences Private Limited, Venkateshwara Chemical Industries Private Limited, Armn Pharmaceutical India Private Limited, Zoithross Life Sciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Guravaiah Nalagam was appointed as Director on 08 Jun 2020. Praveena Nalajam was appointed as Director on 08 Jun 2020.
Yes, Sinogene Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0029688).
The registered office of Sinogene Laboratories is at 4 – 1 – 216111 Flat No. 30 Sai Kiran Residency Karthikeya Nagar N, Acharam, Hyderabad, Telangana, India – 500076.
Sinogene Laboratories operates in the food and beverages industry, in the manufacturing segment.
Sinogene Laboratories can be reached at its registered office: 4 – 1 – 216111 Flat No. 30 Sai Kiran Residency Karthikeya Nagar N, Acharam, Hyderabad, Telangana, India – 500076.